Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leonard

Showing results (571-580 of 686) with videos related to

Pageof 69
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myelomaTomer Mark, Jessica Stern, Jessica R Furst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Outcome of deferred initial therapy in mantle-cell lymphomaPeter Martin, Amy Chadburn, Paul Christos, et al.
Radiology|July 14, 2006
In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticlePanos P Fatouros, Frank D Corwin, Zhi-Jian Chen, et al.
Blood|November 18, 2018
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016Xiaoyu Qu, Hongli Li, Rita M Braziel, et al.
Blood|February 7, 2019
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative studyEric D Hsi, Hongli Li, Andrew B Nixon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2007
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphomaJ P Leonard, J W Friedberg, A Younes, et al.
Cancer|November 2, 2023
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017Shoshana M Rosenberg, Shaylene McCue, Jun He, et al.
Blood|March 28, 2015
A roadmap for discovery and translation in lymphomaDavid M Weinstock, Riccardo Dalla-Favera, Randy D Gascoyne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro propertiesJosette Carnahan, Paul Wang, Richard Kendall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptorV Ling, P W Wu, H F Finnerty, et al.
Pageof 69

Showing results (571-580 of 686) with videos related to

Sort By:
Pageof 69
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myelomaTomer Mark, Jessica Stern, Jessica R Furst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Outcome of deferred initial therapy in mantle-cell lymphomaPeter Martin, Amy Chadburn, Paul Christos, et al.
Radiology|July 14, 2006
In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticlePanos P Fatouros, Frank D Corwin, Zhi-Jian Chen, et al.
Blood|November 18, 2018
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016Xiaoyu Qu, Hongli Li, Rita M Braziel, et al.
Blood|February 7, 2019
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative studyEric D Hsi, Hongli Li, Andrew B Nixon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2007
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphomaJ P Leonard, J W Friedberg, A Younes, et al.
Cancer|November 2, 2023
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017Shoshana M Rosenberg, Shaylene McCue, Jun He, et al.
Blood|March 28, 2015
A roadmap for discovery and translation in lymphomaDavid M Weinstock, Riccardo Dalla-Favera, Randy D Gascoyne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro propertiesJosette Carnahan, Paul Wang, Richard Kendall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptorV Ling, P W Wu, H F Finnerty, et al.
Pageof 69